medical technology company Articles
-
Looking to the Future of Neuro Devices: Exclusive Interview with Alcyone Lifesciences CEO PJ Anand
Alcyone Lifesciences is a medical technology company based out of Lowell, MA, which specializes in central nervous system (CNS) drug delivery platforms for targeted infusions of the brain or spinal cord. Their Thecaflex DRx System was recently awarded Breakthrough Device designation by the FDA, for spinal infusion of therapeutic medications. Medgadget had the opportunity to speak with Alcyone ...
-
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices ...
-
Shoe Sanitizing Stations for Hospitals
During an early 2020 study in Wuhan, China, the epicenter of the COVID-19 pandemic, researchers swabbed multiple surfaces at a healthcare facility to study aerosol and surface distribution. Around 50% of the samples from healthcare workers’ footwear contained genetic material from the SARS-CoV-2 virus. In addition, as medical staff walk around the ward, the virus can be tracked all over the ...
-
Vectorious Begins the VECTOR-HF II Study of its Implantable In-Heart Sensor for Left Atrial Pressure-Guided Patient Self-Management of Heart Failure
For the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations April 26, 2022 08:30 AM Eastern Daylight Time TEL AVIV, Israel–(BUSINESS WIRE)–Vectorious Medical Technologies Ltd., today announced that it has enrolled the first six patients in the ...
By Vectorious
-
Q&A with Dr. Cindy Shu, REDI Fellow
After being awarded the MTPConnect REDI Fellowship Grant in August 2020, Postdoctoral Research Fellow from the Kolling Institute and University of Sydney Royal North Shore Hospital, Dr. Cindy Shu is joining Regeneus for a 12-month project focused on readying Progenza™ for Phase II trials in Japan and the U.S. A Medical Research Future Fund initiative, the grant provides financial support ...
-
Israeli artificial pancreas may one day cure diabetes
The Engineered Micro Pancreas from Betalin Therapeutics is heading closer to clinical trials in humans. Ahead of International Diabetes Day, November 14, Israeli startup Betalin Therapeutics announced that it is beginning the application process for clinical trials of its revolutionary artificial pancreas. Betalin’s Engineered Micro Pancreas (EMP) aims to free patients suffering from the ...
-
Entrepreneur in Residence
Celdara Medical, LLC (CM) is developing a portfolio of preclinical therapeutic assets, platforms, and companies. Each of these has a different development path, and we work with many different modalities, and in many different indications, but everything we do is singularly focused on saving lives and/or improving quality of life. The successful Entrepreneur In Residence will identify one or ...
-
PainShield by NanoVibronix is a type of ultrasound therapy for pain that delivers fast pain relief for nerve and soft tissue damage.
Medical research indicates that nearly 93% of children in America suffer at least one middle ear infection, which is severe enough to see a doctor. Most will suffer repeat occurrences, up to a dozen or more in childhood. These painful episodes are difficult for children, parents, and caregivers. Accurate diagnosis of middle ear infections (Otitis Media) in infants and young children may be ...
-
Remote Oncology Care: Review of Current Technology and Future Directions
Abstract Cancer patients frequently develop tumor and treatment-related complications, leading to diminished quality of life, shortened survival, and overutilization of emergency department and hospital services. Outpatient oncology treatment has potential to leave cancer patients unmonitored for long periods while at risk of clinical deterioration which has been exaggerated during the COVID19 ...
By Oncodisc
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you